Rifaximin

• 产品号: Rifaximin
• CAS号: 80621-81-4
• 分子式: C43H51N3O11
• 分子量: 785.87854

产品别名

• 标题: Rifaximin
• IUPAC标准名: (7S,9Z,11S,12R,13S,14R,15R,16R,17S,18S,19Z,21Z)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.1^4,^7.0^5,^3^5.0^2^6,^3^4.0^2^7,^3^2]heptatriaconta-1,3,5(35),9,19,21,25(36),26(34),28,30,32-undecaen-13-yl acetate
• IUPAC传统名: (7S,9Z,11S,12R,13S,14R,15R,16R,17S,18S,19Z,21Z)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.1^4,^7.0^5,^3^5.0^2^6,^3^4.0^2^7,^3^2]heptatriaconta-1,3,5(35),9,19,21,25(36),26(34),28,30,32-undecaen-13-yl acetate
• 商标名: Xifaxan, Xifaxanta

产品登记号

• CAS号: 80621-81-4
• CHEMBL: 1617
• Chemspider ID: 10482302
• ATC码: A07AA11
• Medline Plus: a604027
• DrugBank ID: DB01220
• 维基百科标题: Rifaximin
• PubChem CID: 6436173
• KEGG ID: D02554
• ATC码: QG51AA06
• ATC码: QJ51XX01
• ATC码: D06AX11
• 美国药典/FDA物质标识码: L36O5T016N

产品性质

• 给药途径: Oral
• 生物利用度: < 0.4%
• 排泄: Fecal (97%)
• 半衰期: 6 hours
• 法定药品分级: Rx-only
• 代谢: Hepatic
• 妊娠期药物分类: C (US)